Furthermore, non-small cell lung cancer (NSCLC) cells modulate the development of human CD1c+ subsets mediated by CD103 and CD205 which trigger the induction of tolerogenic CD1c+ DCs and the expansion of an immune suppressive microenvironment that causes tumor cells to escape immune surveillance [67]. The gene discussed is LY75; the disease is non-small cell lung carcinoma.